Kimia Therapeutics Appoints Imran S. Haque, Ph.D. as Chief Technology Officer

BERKELEY, Calif., March 18, 2025 (Korea Bizwire) – Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S. Haque, Ph.D., to the role of chief technology officer. Dr. Haque, who was most recently senior vice president of AI and digital sciences at Recursion, [...]